Protein Structure Modeling Service Market Report 2026

The protein structure modeling service market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increase in structural biology research, growth in drug target studies, expansion of molecular simulation software, rising academic protein research projects, early use of homology modeling tools.

The protein structure modeling service market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing need for accurate target structure insights, rising demand for rational drug design, expansion of cloud modeling platforms, growing use of simulation in biotech pipelines, higher spending on computational chemistry services. Major trends in the forecast period include growing demand for cloud based structure prediction services, rising use of hybrid protein modeling methods, expansion of molecular docking and simulation services, increasing use of structure validation and refinement tools, higher outsourcing of computational structural analysis.

The growth of personalized medicine is anticipated to drive the growth of the protein structure modeling service market in the coming years. Personalized medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual’s genetic makeup, biological characteristics, and clinical profile to improve outcomes. The growth of personalized medicine is fueled by advancements in genomic and molecular diagnostics, which enable more precise disease profiling and allow treatments to be tailored to individual patient characteristics. Protein structure modeling services support personalized medicine by enabling detailed analysis of patient-specific protein structures, helping researchers design targeted therapies and predict individual drug responses more accurately. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six approvals in 2022. Therefore, the growth of personalized medicine is driving the growth of the protein structure modeling service market.

Companies operating in the protein structure modeling service market are focusing on developing innovative solutions, such as artificial intelligence (AI)-powered protein structure modeling, to enhance structural accuracy and accelerate biomolecular research. Artificial intelligence (AI)-powered protein structure modeling applies advanced algorithms to accurately predict a protein’s 3D structure from its amino acid sequence, which speeds up biological research and drug discovery by reducing reliance on time-consuming and costly experimental techniques. For example, in October 2025, the OpenFold Consortium, a US-based nonprofit organization, launched OpenFold3, its next-generation open-source artificial intelligence (AI)-powered protein structure modeling solution. It is designed to assist researchers and biopharma companies with improved predictive accuracy and workflow efficiency. The solution models the three-dimensional structures of complex proteins, predicts protein-ligand interactions, and integrates with protein design tools such as ProteinMPNN to support early-stage drug discovery and materials science research.

In July 2023, BioNTech SE, a Germany-based biotechnology company, acquired InstaDeep Ltd. for an undisclosed amount. Through this acquisition, BioNTech aims to bolster its drug discovery and development capabilities by integrating InstaDeep’s artificial intelligence and machine learning technologies to improve protein structure modeling, accelerate target identification, and enhance structure-based drug design across its therapeutic programs. InstaDeep Ltd. is a UK-based AI company providing research and development solutions for protein structure modeling and prediction.

Major companies operating in the protein structure modeling service market are Thermo Fisher Scientific Inc, Dassault Systèmes SE, Cadence Design Systems Inc, Bruker Corporation, SWISS-MODEL, Revvity Inc, QIAGEN N.V., GenScript Biotech Corporation, Certara USA Inc, Cresset Group Ltd, Schrödinger Inc, Zymeworks Inc, Recursion Inc, Creative Biostructure Inc, Dnastar Inc, Bioinformatics Solutions Inc, Chemical Computing Group ULC, SilcsBio LLC, Cyrus Biotechnology Inc, and CD ComputaBio Inc.

Tariffs are influencing the protein structure modeling service market by increasing the cost of imported compute hardware and specialized simulation infrastructure. Duties on high end processors and storage systems are raising operating costs for service providers. Cloud and hybrid deployment segments that rely on global hardware supply chains are the most affected. Regions dependent on imported servers and accelerators, especially in asia pacific and europe, are seeing budget pressure. Service pricing and project timelines are being adjusted to manage higher infrastructure costs. At the same time, tariffs are encouraging local data center expansion and regional compute investments. This supports domestic technology providers and improves local service capacity.

The protein structure modeling service market research report is one of a series of new reports that provides protein structure modeling service market statistics, including protein structure modeling service industry global market size, regional shares, competitors with a protein structure modeling service market share, detailed protein structure modeling service market segments, market trends and opportunities, and any further data you may need to thrive in the protein structure modeling service industry. This protein structure modeling service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein structure modeling service is a technology-based solution that provides scalable cloud-based and on-site computational resources along with software platforms to predict, examine, and display the three-dimensional configurations of proteins. It applies bioinformatics, molecular modeling, and simulation techniques to analyze protein folding, interactions, and active regions. It is utilized to deliver precise structural knowledge that supports target discovery, rational drug development, and functional protein analysis.

The core service types of protein structure modeling include homology modeling, threading, ab initio, and hybrid methods. Homology modeling is a technique used to predict the three-dimensional structure of a protein based on the known structures of related homologous proteins. These services are offered through various deployment modes, including cloud-based platforms and on-premise solutions, and are available under different pricing models, such as prepaid and subscription-based plans. They are applied across multiple domains, including drug discovery, protein engineering, functional annotation, structural biology, and other areas, and cater to diverse end users such as pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other organizations.

The protein structure modeling service market includes revenues earned by entities through computational protein structure prediction, molecular docking and simulation, structural validation and refinement, protein-ligand interaction analysis, and bioinformatics consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.